⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 6, 2012Journal of Surgical Oncology

Overexpression of MMSET in endometrial cancer: A clinicopathologic study

Min Xiao Shanshan Yang Jie Chen Xiaoming Ning Liyuan Guo Kejin Huang Sui Li-hua

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Overexpression of MMSET may contribute to the progression of endometrial cancer and also may serve as a new biomarker to predict the prognosis of endometrial cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Xiao et al. (2012) studied this question.

synapsesocial.com/papers/69dd70bf26032fe00d10136c https://doi.org/10.1002/jso.23234

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Cancer Statistics, 2009Registry Study · 2009 · 9,697 citations
2Endometrial CarcinomaPrognostic Study · 1996 · 460 citations
3Prognostic Significance of Angiogenesis and Ki-67, p53, and p21 Expression: A Population-Based Endometrial Carcinoma StudyCohort Study · 1999 · 164 citations
4Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial CancerPrognostic Study · 2011 · 119 citations
5The Target of the NSD Family of Histone Lysine Methyltransferases Depends on the Nature of the SubstrateOriginal Research · 2009 · 289 citations
6MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cellsOriginal Research · 2008 · 123 citations
7The Histone Methyltransferase and Putative Oncoprotein MMSET Is Overexpressed in a Large Variety of Human TumorsOriginal Research · 2011 · 139 citations
8The multiple myeloma–associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicityPrognostic Study · 2007 · 157 citations
9Concentration‐Based Short‐Course Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at Interval Cytoreductive Surgery (iCRS) for Advanced Ovarian Cancer: Final Analysis of Overall Survival in a Phase 2 TrialJournal of Surgical Oncology · 2026
10Wound‐Healing Complications Disrupt Early Patient‐Reported Recovery After Limb‐Sparing Soft Tissue Sarcoma SurgeryJournal of Surgical Oncology · 2026

More from Journal of Surgical Oncology

More from Harbin Medical University